OTC Markets OTCPK - Delayed Quote USD

CanadaBis Capital Inc. (CNADF)

0.0658

+0.0003

+(0.46%)

At close: April 2 at 10:36:38 AM EDT

CANADABIS ANNOUNCES CLOSING OF FINANCING

CanadaBis Capital Inc. ("CanadaBis") (TSXV: CANB) is pleased to announce that it has closed the final tranche of the previously announced brokered private placement of 11% unsecured convertible debentures (the "Debentures") at a price of $1,000 per Debenture (the "Financing"). Closing of this final tranche consisted of the issuance of 1,415 Debentures for aggregate gross proceeds of $1,415,000. Over the two tranches, the total Financing raised aggregate gross proceeds of $4,035,000. Research Cap

CNW Group 4 days ago

CNADF
+0.46%
CANADABIS ANNOUNCES CLOSING OF FIRST TRANCHE OF FINANCING FOR $2.6 MILLION

CanadaBis Capital Inc. ("CanadaBis") (TSXV: CANB) is pleased to announce that it has closed the first tranche of the previously announced brokered private placement of 11% unsecured convertible debentures (the "Debentures") at a price of $1,000 per Debenture (the "Financing"). Closing of the first tranche consisted of the issuance of 2,620 Debentures for aggregate gross proceeds of $2,620,000.

CNW Group 16 days ago

CNADF
+0.46%
CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Revenue Q2 F2025 Resulting in $9M Gross with $96k in NET Earnings and an Adjusted EBITDA of $434,158.00

CanadaBis Capital Inc. ("CanadaBis" or the "Company") (TSXV: CANN), a leading player in the cannabis sector, is pleased to announce its financial results for the second quarter of 2025, ending January 31, 2025.

CNW Group 19 days ago

CNADF
+0.46%
CANADABIS ANNOUNCES UPSIZE OF CONVERTIBLE DEBENTURE FINANCING TO $4.5 MILLION

CanadaBis Capital Inc. ("CanadaBis") (TSXV: CANB) is pleased to announce that, due to strong investor demand, the brokered private placement previously announced on March 12, 2025 (the "March 12 Release") has been increased to up to 4,500 unsecured convertible debentures (the "Debentures") at a price of $1,000 per Debenture, for gross proceeds of up to $4.5 million (the "Financing"). Research Capital Corporation is acting as the sole agent and sole bookrunner (the "Agent").

CNW Group 22 days ago

CNADF
+0.46%
SIMPLY SOLVENTLESS ANNOUNCES HIGHLY ACCRETIVE ALL SHARE DEAL TO ACQUIRE CANADABIS (STIGMA GROW), CREATING #2 CONCENTRATES AND #5 PREROLL PRODUCER, AND CANADABIS ANNOUNCES $2.5 MILLION CONVERTIBLE DEBENTURE FINANCING

Simply Solventless Concentrates Ltd. (TSXV: HASH) (OTC: SSCLCF) ("SSC") and CanadaBis Capital Inc. ("CanadaBis" or "Stigma Grow") (TSXV: CANB) are pleased to announce that they have entered into an arrangement agreement (the "Arrangement Agreement") dated March 11, 2025 pursuant to which SSC will acquire all of the issued and outstanding common shares of CanadaBis by way of a court approved plan of arrangement under the Business Corporations Act (Alberta) (the "Transaction"). Upon closing of the

CNW Group last month

CNADF
+0.46%
SSLCF
CanadaBis Capital announces the appointment of Mr. Shane Chana as Chief Financial Officer

CanadaBis Capital (CANB.V) a leader in the Canadian cannabis industry, is proud to announce the appointment of Mr. Shane Chana as Chief Financial Officer.

CNW Group 2 months ago

CNADF
+0.46%
Canadabis Capital Celebrates Historic Milestone: First Shipment of Stigma Grow Products to Portugal

Canadabis Capital is thrilled to announce a momentous milestone in the history of Stigma Grow with the successful shipment of its premium cannabis products to Portugal. This significant event marks Stigma Grow's first international export, opening new doors for growth and expansion in the European market.

CNW Group 3 months ago

CNADF
+0.46%
CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Record Revenue Q1 F2025 Resulting in $9.6M Gross with $321,569 in NET Earnings and an Adjusted EBITDA of $675,892

CanadaBis Capital (the "Company" or "CanadaBis Capital") (TSXV: CANB.V) a premium cannabis and concentrates producer, is pleased to announce its First Quarter Fiscal 2025 financial results for the three month period ending October 31, 2024.

CNW Group 3 months ago

CNADF
+0.46%
Declining Stock and Decent Financials: Is The Market Wrong About CanadaBis Capital Inc. (CVE:CANB)?

With its stock down 8.3% over the past month, it is easy to disregard CanadaBis Capital (CVE:CANB). However, stock...

Simply Wall St. 4 months ago

CNADF
+0.46%
CanadaBis Capital Reports Positive Net Income and Strong Financial Performance for Fiscal Year End 2024

CanadaBis Capital (CANB.V) a leader in the Canadian cannabis industry, is proud to announce its financial results for the year ending July 31, 2024. The company is pleased to report a positive net income of $600,285, marking a significant achievement as CanadaBis continues to grow and solidify its position in the market.

CNW Group 4 months ago

CNADF
+0.46%
CanadaBis Capital Third Quarter 2024 Earnings: EPS: CA$0.072 (vs CA$0.009 in 3Q 2023)

CanadaBis Capital ( CVE:CANB ) Third Quarter 2024 Results Key Financial Results Revenue: CA$3.97m (down 34% from 3Q...

Simply Wall St. 9 months ago

CNADF
+0.46%
CANADABIS CAPITAL REPORTS STRONG FINANCIAL RESULTS FOR Q3 2024

CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce results from our second quarter fiscal 2024, represented by our tenth consecutive quarter generating net revenue. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis ("MD&A") are filed on SEDAR at www.sedarplus.ca. This quarter reflects another period generating positive earnings and Adjusted EBITDA1 for Ca

CNW Group 9 months ago

CNADF
+0.46%
CanadaBis Capital Inc.'s (CVE:CANB) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

It is hard to get excited after looking at CanadaBis Capital's (CVE:CANB) recent performance, when its stock has...

Simply Wall St. 9 months ago

CNADF
+0.46%
Canadabis Capital Expands into European Market with EU-GMP Partners

Canadabis Capital (TSXV: CANB) with Sub Stigma Grow, a leading Canadian cannabis company, is pleased to announce its strategic expansion into the European market through a significant distribution agreement. This marks a pivotal moment in Stigma Grows history, as the company's innovative products will now be introduced to international markets.

CNW Group 11 months ago

CNADF
+0.46%
Canadabis Capital Unveils New 60%+ Double-Infused Pre-Roll under Dab Bods Brand, Setting New Standard for THC Potency in Canadian Market

CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), – Canadabis Capital, and its shareholdings in Stigma Grow a leading innovator in the Canadian cannabis industry, is thrilled to announce the launch of the latest addition to the Dab Bods brand lineup – a ground breaking 60%+ double-infused pre-roll. This new offering sets a new benchmark for THC potency in the Canadian market, catering to cannabis enthusiasts seeking a premium, high-potency experience.

CNW Group 11 months ago

CNADF
+0.46%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

CanadaBis Capital Inc. (CNADF)

CANADABIS ANNOUNCES CLOSING OF FINANCING

CANADABIS ANNOUNCES CLOSING OF FIRST TRANCHE OF FINANCING FOR $2.6 MILLION

CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Revenue Q2 F2025 Resulting in $9M Gross with $96k in NET Earnings and an Adjusted EBITDA of $434,158.00

CANADABIS ANNOUNCES UPSIZE OF CONVERTIBLE DEBENTURE FINANCING TO $4.5 MILLION

SIMPLY SOLVENTLESS ANNOUNCES HIGHLY ACCRETIVE ALL SHARE DEAL TO ACQUIRE CANADABIS (STIGMA GROW), CREATING #2 CONCENTRATES AND #5 PREROLL PRODUCER, AND CANADABIS ANNOUNCES $2.5 MILLION CONVERTIBLE DEBENTURE FINANCING

CanadaBis Capital announces the appointment of Mr. Shane Chana as Chief Financial Officer

Canadabis Capital Celebrates Historic Milestone: First Shipment of Stigma Grow Products to Portugal

CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Record Revenue Q1 F2025 Resulting in $9.6M Gross with $321,569 in NET Earnings and an Adjusted EBITDA of $675,892

Declining Stock and Decent Financials: Is The Market Wrong About CanadaBis Capital Inc. (CVE:CANB)?

CanadaBis Capital Reports Positive Net Income and Strong Financial Performance for Fiscal Year End 2024

CanadaBis Capital Third Quarter 2024 Earnings: EPS: CA$0.072 (vs CA$0.009 in 3Q 2023)

CANADABIS CAPITAL REPORTS STRONG FINANCIAL RESULTS FOR Q3 2024

CanadaBis Capital Inc.'s (CVE:CANB) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Canadabis Capital Expands into European Market with EU-GMP Partners

Canadabis Capital Unveils New 60%+ Double-Infused Pre-Roll under Dab Bods Brand, Setting New Standard for THC Potency in Canadian Market